On May 29, 2012, the FDA issued a warning for consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets sold on the Internet. Adderall, FDA-approved to treat attention deficit hyperactivity disorders (ADHD), is a prescription drug classified as a controlled substance. Under the classification, special controls are required for dispensing by pharmacists. In 2010, more than 18 million prescriptions were written for Adderall, up 13.4 percent from 2009, according to IMS Health.
Preliminary FDA laboratory tests revealed that the counterfeit version of Adderall contained the wrong active ingredients. The counterfeit product contained tramadol and acetaminophen, ingredients in medicines used to treat acute pain. The FDA included in its warnings visual cues for consumers. Physically, the counterfeit Adderall tablets are round, white and are not marked with identification such as letters or numbers. The counterfeit versions of Adderall should be considered as unsafe, ineffective and potentially harmful. According to the FDA’s release, authentic Adderall 30 mg tablets produced by Teva are round, orange/peach, and scored tablets with “dp” embossed on one side and “30” on the other side of the tablet. Teva’s Adderall 30 mg tablets are packaged only in a 100-count bottle with the National Drug Code (NDC) 0555-0768-02 listed.
Currently on the FDA’s drug shortage list, the FDA noted that consumers should be extra cautious when buying medicines from online sources. Rogue websites and distributors may especially target medicines in short supply for counterfeiting.